Anchor Capital Advisors’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-6,125
Closed -$499K 282
2016
Q2
$499K Sell
6,125
-516,561
-99% -$39.3M 0.01% 213
2016
Q1
$37.3M Sell
522,686
-82,159
-14% -$5.51M 0.9% 45
2015
Q4
$43M Sell
604,845
-236,269
-28% -$15.9M 1.09% 34
2015
Q3
$51.7M Sell
841,114
-13,413
-2% -$938K 1.32% 25
2015
Q2
$62M Sell
854,527
-302,594
-26% -$22.3M 1.39% 19
2015
Q1
$88.9M Sell
1,157,121
-135,162
-10% -$9.68M 1.93% 6
2014
Q4
$86.7M Sell
1,292,283
-45,026
-3% -$2.84M 1.75% 9
2014
Q3
$81.1M Sell
1,337,309
-140,451
-10% -$8.65M 1.68% 10
2014
Q2
$86.7M Buy
1,477,760
+173,302
+13% +$10.1M 1.67% 10
2014
Q1
$75.6M Buy
1,304,458
+667,267
+105% +$35.8M 1.5% 17
2013
Q4
$34.1M Buy
637,191
+554,691
+672% +$32.9M 0.68% 58
2013
Q3
$5.1M Buy
82,500
+19,000
+30% +$1.14M 0.11% 114
2013
Q2
$3.85M Buy
+63,500
New +$3.78M 0.08% 123

Other funds holding DGX

Anchor Capital Advisors's DGX Position: Q3 2016 in Review

Anchor Capital Advisors sold out of Quest Diagnostics (DGX) in Q3 2016, closing a stake of 6,125 shares — an estimated $499K sold.

Anchor Capital Advisors first reported a position in DGX in Q2 2013 and held it in 13 quarters. The position peaked at $88.9M in Q1 2015. 559 funds tracked by Wall St. Rank hold DGX as of Q3 2016.

  • Anchor Capital Advisors reported no remaining Quest Diagnostics position as of Q3 2016 after selling out during the quarter.
  • Anchor Capital Advisors sold 6,125 Quest Diagnostics shares in Q3 2016, an estimated $499K.
  • Anchor Capital Advisors first reported a position in Quest Diagnostics in Q2 2013 and held it in 13 quarters.
  • Anchor Capital Advisors's Quest Diagnostics position peaked at $88.9M in Q1 2015.
  • 559 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2016.

Based on Anchor Capital Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.